Clinical Trial of Favipiravir Treatment of Patients With COVID-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
To verify that the efficacy of favipiravir exceeds that of the actual supportive care (symptomatic therapy) in SARS-CoV-2 infected patients (COVID-19 patients) with mild pneumonia, using the time required to improve clinical symptoms as the primary endpoint.
Epistemonikos ID: a500ed34a319cf32150fb70991f61e43c37644d9
First added on: Oct 24, 2020